← FDA Drug Approvals (Drugs@FDA)
ABACAVIR || DOLUTEGRAVIR || LAMIVUDINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EMCURE PHARMS LTD · Approved 2024-12-05
Drug application
- FDA Application #
ANDA212181- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ABACAVIR || DOLUTEGRAVIR || LAMIVUDINE
- Generic name
- Abacavir || Dolutegravir || Lamivudine
- Active ingredients
- ABACAVIR || DOLUTEGRAVIR || LAMIVUDINE
- Dosage form
- TABLET
- Route
- —
- Marketing status
- None (Tentative Approval)
- Sponsor
- EMCURE PHARMS LTD
- First approval
- 2024-12-05
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown